Year None20242023202220212020 NEWS RELEASE 04.16.2024 AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024 NEWS RELEASE 03.09.2024 AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024 NEWS RELEASE 03.06.2024 AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND NEWS RELEASE 02.29.2024 AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE NEWS RELEASE 02.26.2024 AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO NEWS RELEASE 02.19.2024 AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE NEWS RELEASE 02.09.2024 AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE NEWS RELEASE 02.06.2024 AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS NEWS RELEASE 02.01.2024 AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS NEWS RELEASE 01.03.2024 AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE